Self-Efficacy. The Effect of Self-Efficacy on Treatment Outcomes of Clients Enrolled in a Methadone Treatment Program in Rural Maryland

Size: px
Start display at page:

Download "Self-Efficacy. The Effect of Self-Efficacy on Treatment Outcomes of Clients Enrolled in a Methadone Treatment Program in Rural Maryland"

Transcription

1 The Effect of Self-Efficacy on Treatment Outcomes of Clients Enrolled in a Methadone Treatment Program in Rural Maryland Bonnie A. Franckowiak, DNP, FNP, CARN-AP Self-Efficacy The belief in one s capabilities to organize and execute the courses of action required to manage prospective situations. - Albert Bandura, 1986

2 Self-Efficacy is belief in one s ability to succeed at tasks. General Self-Efficacy is belief in one s general ability to succeed at tasks. Specific Self-Efficacy refers to beliefs about one s ability to handle specific tasks. Why Study Self-Efficacy?

3 Addiction is a Medical Disease Addiction is a chronic, relapsing brain disease, which has implications not only as an individual health problem, but also as a public health problem. It impacts the drug abuser and the community on a physical, mental, psychological and social level. (Qureshi, Al-Ghamdy, & Al-Habeeb, 2000) Background: Opiate Addiction 24.6 million Americans used illicit drugs in 2013 (9.4%) National cost is approx. $700 billion annually >8,000 new users daily (SAMHSA, 2014)

4 Background (cont.) Public health problem with global implications Contributes to global mortality and morbidity (NIDA, 2011) Global Burden of Disease DALY = Disability Adjusted Life Years The number of years of potential life lost due to premature mortality and the years of productive life lost due to disability.

5 Global Burden of Substance Abuse Drug dependence responsible for 20 million DALYs in 2010 Opioid dependence was the largest contributor, with 9.2 million Highest burden in higher income countries Illustrates increased need for treatment (Degenhardt, et al. 2013) Treatment: A Research-based Guide (NIDA, 1999) No single treatment is appropriate for all individuals. Treatment must attend to multiple need of the individual, not just drug use. Remaining in treatment for an adequate period of time is critical for treatment effectiveness.

6 Medication assisted treatment (MAT) using Methadone Gold standard of opiate treatment Strict state and federal regulations Individualized according to need MAT (cont.) Pharmacology, counseling, and behavioral therapy Comprehensive approach; Individualized care Goal: return to a state of health and well-being, and function well in family and community Low cost, safe, and effective; Accepted world-wide

7 LITERATURE REVIEW Literature Review Retention in treatment Psychosocial support Behavior change Self-Efficacy Health Belief Model

8 Retention in Treatment Client satisfaction leads to improved outcomes. Kelly, O Grady, Mitchell, Brown & Schwartz; 2011 Chronic illness is best treated collaboratively by client and provider. VonKorff, Gruman, Curry & Wagner; 1997 Adequate methadone dosing, psychiatric care, and behavioral counseling are key to successful treatment. Ciraulo, Piechniczek-Buczek & Iscan; 2003 Individualized treatment plans are associated with better retention and outcomes. Hser, Evans, Huang & Anglin; 2004 Psychosocial Support Satisfaction and rapport with staff leads to a decrease in illicit drug use, better compliance with treatment, and improved outcomes. Joe, Simpson, Dansereau Rowan-Szal; 2001 Clients who felt that needs were met during treatment stayed abstinent longer at 1 year follow up. Zhang, Gerstein & Freidmann; 2008 Outcomes improve when psychosocial support is added to medication treatment, compared to medication alone. Amato, Minozzi, Davoli, Vecchi, Ferri & Mayet; 2009

9 Behavior Change Motivation is an important factor in behavior change Kelly, Zyzanski & Alemagno; Self-efficacy affects the decision whether or not to initiate behavior change. Stewart, Wolfe, Maeder & Hartz; 1996 Maintenance of new behaviors is related to self-efficacy. Scherbaum; 2008 Self- Efficacy Positive health behavior is related to high self-efficacy. Schwarzer & Fuchs; 1995 Efforts to improve self-efficacy lead to improved treatment outcome and retention. Bourbeau; 2008 : Senbanjo, Wolff, Marshall & Strang; 2009 Alcoholics with high self-efficacy resisted temptation to drink for longer time periods. Vielva & Iraurgi; 2001: Allsop,Saunders&Phillips;2000

10 Self-efficacy is a fluid, dynamic concept. Why is Self-Efficacy important? Past Performance Verbal Persuasion Vicarious Experience Psychological / Emotional States Self-Efficacy Feelings Thoughts Motivation Actions

11 Health Belief Model (HBM) One of the most widely accepted and frequently used models for study and implementation of behavior change. Harrison, Mullen & Green; 1992 Proven useful in improving patient compliance in many studies related to various chronic illnesses. HEALTH B Orel et al.; 2010: Ghaddar et al.; 2009: Koch; 2002 HBM (cont.) Four conditions for behavior change: The belief that one is at risk of developing a specific condition. The belief that the risk is serious and the consequences are undesirable. The belief that the risk will be reduced by behavior change. The belief that barriers to behavior change can be overcome and managed. (Janz & Becker, 1984)

12 Health Belief Model Demographic variables (age, sex, race, ethnicity, etc.) Sociopsychological variables Perceived benefits of preventive action minus Perceived barriers to preventive action Perceived Susceptability to Disease X Perceived Seriousness (Severity) of Disease X Perceived Threat of Disease X Likelihood of Taking Recommended Preventive Health Action Cues to Action Mass media campaigns Advice from others Reminder postcard from physician/dentist Illness of family member or friend Newspaper or magazine article Janz & Becker, 1984 METHODOLOGY

13 Purpose: To determine if measurement of self-efficacy can be a useful tool in treatment of the opiate addicted client. Research Questions 1. Are MAT and self-efficacy related? 2. Are self-efficacy and treatment outcomes related?

14 The General Self-efficacy Scale (GSE) 1. I can always manage to solve difficult problems if I try hard enough. 2. If someone opposes me, I can find the means to get what I want. 3. It is easy for me to stick to my aims and accomplish my goals. 4. I am confident that I could deal efficiently with unexpected events. 5. Thanks to my resourcefulness, I can handle unforeseen circumstances. 6. I can solve most problems if I invest the necessary effort. 7. I can remain calm when facing difficulties because I can rely on my coping abilities. 8. When I am confronted with a problem, I can usually find several solutions. 9. If I am in trouble, I can usually think of a solution. 10. Responses: I can usually 1= Not handle at all true. whatever 2 = Hardly comes true. my 3 way. = Moderately true. 4 = Exactly true. English version by Schwarzer & Jerusalem, 1995 Specific Self-efficacy Additional questions relating specifically to opiate dependence added by researcher. 11. If I ran into old friends who offered me pills or heroin, I could resist. 12. I can stay away from people I used to use with, and I feel strong. 13. If I was in a situation where people were using drugs, I would have the strength to leave. 14. I feel that I am able to cope with stress in ways other than using drugs. Responses: 1= Not at all true. 2 = Hardly true. 3 = Moderately true. 4 = Exactly true. Franckowiak, 2011

15 Variable s change in self-efficacy scores number of opiate-free urines monthly group attendance monthly individual counseling sessions STUDY DESIGN

16 The Study Admission process including GSE Initiate Standard MAT After 6 months +/- 4 days Obtain informed consent Repeat GSE Retrospective record review of outcome measures Study Site: Serenity Health, LLC Elkton, MD Site Demographics: 96% Caucasian, 3% African American 54% female, 70% unemployed, 4% disabled 80% Medicaid, 20% self-pay Average age 34 years

17 Analysis of Data QUESTION #1: Are MAT and self-efficacy related? Comparison of (Post- minus Pre-treatment) scores using Paired t-test QUESTION #2: Are self-efficacy and treatment outcomes related? Correlation of group and individual sessions, and number of opiate-negative urine screens using Pearson Correlation RESULTS

18 MEAN PRE-TREATMENT GSE SCORES BY GENDER Pre GSE (General) Pre GSE (Specific) Pre GSE (Total) Gender Mean N Std. Dev. Females Males Combined Females Males Combined Females Males Combined MEAN POST-TREATMENT GSE SCORES BY GENDER Post GSE (General) Post GSE (Specific) Post GSE (Total) Females Males Combined Females Males Combined Females Males Combined

19 COMPARISON OF PRE- & POST- TREATMENT GSE SCORES Post-Pre GSE score (general) Post-Pre GSE score (specific) Post-Pre GSE score (total) t p value Range Average Increase Research Question #1 Is MAT related to self-efficacy? In this study, MAT does appear to be related to self-efficacy.

20 CORRELATION OF GSE SCORES AND NUMBER OF OPIATE NEGATIVE URINE SCREENS Negative Urine Pre GSE (General) Pre GSE (Specific) Pre GSE (Total) Pearson Correlation Sig. (2-tailed) N CORRELATION OF GSE SCORES AND INDIVIDUAL AND GROUP SESSIONS Individual Sessions Group Sessions Pearson Correlation Sig. (2- tailed) Pearson Correlation Sig. (2- tailed) Pre GSE (General) Pre GSE Pre GSE (Specific) (Total) N

21 Research Question #2 Are self-efficacy and treatment outcomes related? No correlation was found between self-efficacy scores and any of the treatment outcomes measured. Descriptive Data High GSE scores yielded more opiate negative urine screens. Subjects with high GSE scores preferred groups. Subjects with low GSE scores preferred individual sessions. Five subjects had unchanged or lowered GSE scores. 28 of 50 subjects identified completed the study.

22 Transferred to other treatment facility 3 Moved out of area Medical issues / Hospitalization Incarceration Administrative discharge Referred to pain management Left AMA Unknown Participants who did not complete the study (n = 22) DISCUSSION & RECOMMENDATIONS

23 Strengths of the Study Homogeneity of sample All subjects received same MAT protocol Inter-rater reliability Met 6 month minimum for MAT Limitations of the Study Small sample size High attrition rate Did not control for additional group attendance Did not control for type of group attended

24 Recommendations for Research Replicate with larger sample size and longer duration. Add measure of stress level. Assess motivation for treatment. Control for other variables (onset of drug use, treatment history, and concurrent substance use). Add control group who receives an intervention to increase self-efficacy. Recommendations for Practice Repeat GSE at intervals throughout treatment, and incorporate into Relapse Prevention programs. Continue use of GSE testing as an aid in treatment planning and counselor assignment. Use GSE testing to strengthen patient assessment, and view of whole person.

25 Follow Up at One Year Of the 28 subjects who completed the original study, 22 remained in treatment.

26 Final thought... Self-belief does not necessarily ensure success, but selfdisbelief assuredly spawns failure. - Albert Bandura From Self-Efficacy: The exercise of Control, 1997

27 Questions & Discussion Thank you.

Assessing Readiness To Change

Assessing Readiness To Change Assessing Readiness To Change Transtheoretical Model The Transtheoretical Model describes the stages of behavior prior to change. It focuses on the individual s decision making. This model involves the

More information

The Value of Engagement in Substance Use Disorder (SUD) Treatment

The Value of Engagement in Substance Use Disorder (SUD) Treatment The Value of Engagement in Substance Use Disorder (SUD) Treatment A Report from Allegheny HealthChoices, Inc. June 2016 Introduction When considering substance use disorder (SUD) treatment, the length

More information

GOALS AND OBJECTIVES

GOALS AND OBJECTIVES SUBOXONE AND VIVITROL: ARE THERE DISPARITIES SURFACING IN MEDICATION ASSISTED TREATMENTS? P R E S E N T E D B Y D R. K I AM E M AH A N I A H & D R. M Y E C H I A M I N T E R - J O R D AN GOALS AND OBJECTIVES

More information

Improving Outcomes in Methadone Treatment

Improving Outcomes in Methadone Treatment Improving Outcomes in Methadone Treatment Cognitive/Behavioral Treatment Contingency Management Michael J. McCann, MA Matrix Institute on Addictions COMP Symposium September 11, 2007 Overview of Presentation

More information

The Importance of Psychological Treatment and Behavioral Support

The Importance of Psychological Treatment and Behavioral Support The Importance of Psychological Treatment and Behavioral Support Michael W. Otto, PhD Department of Psychological and Brain Science Boston University Conflicts and Acknowledgements No industry funding

More information

Mindfulness and self- regulation skills - Introduction

Mindfulness and self- regulation skills - Introduction Mindfulness and self- regulation skills - Introduction Because FASD is a neurodevelopmental disability that can affect cognitive skills and executive functioning (i.e. inhibition, problem solving, attention,

More information

Treatment Issues: The Opiate Crisis Among Us

Treatment Issues: The Opiate Crisis Among Us Treatment Issues: The Opiate Crisis Among Us Presenter: Jessica Cirillo, BS, MA, ACRPS Clinical Supervisor & Relapse Prevention Specialist with Mirmont Treatment Center Facts About Addiction Addiction

More information

Understanding and Combating the Heroin Epidemic

Understanding and Combating the Heroin Epidemic Understanding and Combating the Heroin Epidemic Kelly Dunn, Ph.D. Assistant Professor; Johns Hopkins School of Medicine Department of Psychiatry and Behavioral Sciences 1 Talk Outline What is causing the

More information

IntNSA Webinar Series

IntNSA Webinar Series BUPRENORPHINE CLINIC: A MULTIDISCIPLINARY MODEL FOR OPIOID MAINTENANCE THERAPY Stephen Strobbe, PhD, RN, NP, PMHCNS-BC, CARN-AP Monday, June 4, 2012 IntNSA Webinar Series Funding for this webinar was made

More information

Trigger. Myths About the Use of Medication in Recovery BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS

Trigger. Myths About the Use of Medication in Recovery BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS Module VI Counseling Buprenorphine Patients Myths About the Use of Medication in Recovery! Patients are still addicted!

More information

3/6/2017. Grassroots Strategies for Improving Adherence. Learning Objectives

3/6/2017. Grassroots Strategies for Improving Adherence. Learning Objectives Grassroots Strategies for Improving Adherence Amy Knight, PhD Director of Rehabilitation Psychology Department of Physical Medicine & Rehabilitation University of Alabama Birmingham Nothing to Disclose

More information

Providing Medication Assisted Treatment for Opioid Use Disorder in Family Medicine Clinics in Vermont

Providing Medication Assisted Treatment for Opioid Use Disorder in Family Medicine Clinics in Vermont University of Vermont ScholarWorks @ UVM Family Medicine Block Clerkship, Student Projects College of Medicine 2016 Providing Medication Assisted Treatment for Opioid Use Disorder in Family Medicine Clinics

More information

The available evidence in the field of treatment of opiate: The experience of developing the WHO clinical guidelines

The available evidence in the field of treatment of opiate: The experience of developing the WHO clinical guidelines The available evidence in the field of treatment of opiate: The experience of developing the WHO clinical guidelines Background, Objectives and Methods Systematic reviews (SRs) published by Cochrane Drugs

More information

Clinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT)

Clinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT) Clinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT) What has changed? Effective January 16, 2018, Coordinated Care will change the requirement for form HCA 13-333 Medication

More information

Improving the Quality of Addiction Treatment

Improving the Quality of Addiction Treatment Improving the Quality of Addiction Treatment Expanding Access to Medication-Assisted Treatment in Residential Addiction Treatment Programs Webinar sponsored by RTI International January 18, 2018 RTI International

More information

Methadone Maintenance 101

Methadone Maintenance 101 Methadone Maintenance 101 OTP/DAILY DOSING CLINICS - ANDREW PUTNEY MD Conflicts of Interest - Employed by Acadia HealthCare 1 Why Methadone? At adequate doses methadone decreases opioid withdrawal symptoms

More information

THE UNSTABLE BUPRENORPHINE- NALOXONE PATIENT

THE UNSTABLE BUPRENORPHINE- NALOXONE PATIENT Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences THE UNSTABLE BUPRENORPHINE- NALOXONE PATIENT MARK DUNCAN MD UNIVERSITY OF WASHINGTON SPEAKER DISCLOSURES Any conflicts

More information

Evidence-Based Practice: Psychosocial Interventions

Evidence-Based Practice: Psychosocial Interventions Evidence-Based Practice: Psychosocial Interventions Maxine Stitzer, Ph.D. Johns Hopkins Univ SOM NIDA Blending Conference June 3, 2008 Cincinnati, Ohio Talk Outline What is an evidence-based practice?

More information

FY17 SCOPE OF WORK TEMPLATE. Name of Program/Services: Medication-Assisted Treatment: Buprenorphine

FY17 SCOPE OF WORK TEMPLATE. Name of Program/Services: Medication-Assisted Treatment: Buprenorphine FY17 SCOPE OF WORK TEMPLATE Name of Program/Services: Medication-Assisted Treatment: Buprenorphine Procedure Code: Modification of 99212, 99213 and 99214: 99212 22 99213 22 99214 22 Definitions: Buprenorphine

More information

IMPACT OF INCLUSION/ EXCLUSION CRITERIA ON ENROLLMENT

IMPACT OF INCLUSION/ EXCLUSION CRITERIA ON ENROLLMENT 2014 CTN Web Seminar Series IMPACT OF INCLUSION/ EXCLUSION CRITERIA ON ENROLLMENT Presented by: Robert Lindblad, MD & Gaurav Sharma, PhD NIDA Clinical Coordinating & Data and Statistics Centers The EMMES

More information

Child Welfare and MOMS: Building Partnerships to Improve Care

Child Welfare and MOMS: Building Partnerships to Improve Care Child Welfare and MOMS: Building Partnerships to Improve Care Goals Develop collaborative partnerships between MOMS pilot sites and child welfare agencies: Facilitate successful outcomes for clients Jointly

More information

Clinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT)

Clinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT) Clinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT) For Apple Health clients served Fee-for-Service and through contracted Medicaid Managed Care Organizations Updated January

More information

State Targeted Opioid Response Initiative (STORI) Fee-for-Service (FFS) Open Enrollment

State Targeted Opioid Response Initiative (STORI) Fee-for-Service (FFS) Open Enrollment State Targeted Opioid Response Initiative (STORI) Fee-for-Service (FFS) Open Enrollment DEPARTMENT OF HUMAN SERVICES (DHS) DIVISION OF MENTAL HEALTH & ADDICTION SERVICES (DMHAS) STORI INFORMATIONAL WEBINAR

More information

Noel Schenk MD. Davis Behavioral Health

Noel Schenk MD. Davis Behavioral Health Noel Schenk MD Davis Behavioral Health Michael Botticelli Director of National Drug Control Policy What is Addiction? Addiction is defined as a chronic, relapsing brain disease that is characterized by

More information

Treatment Works, Kentucky: An Overview of Substance Abuse Treatment Outcomes from KTOS

Treatment Works, Kentucky: An Overview of Substance Abuse Treatment Outcomes from KTOS Treatment Works, Kentucky: An Overview of Substance Abuse Treatment Outcomes from KTOS Robert Walker, M.S.W., L.C.S.W. University of Kentucky Center on Drug and Alcohol Research Kentucky Substance Abuse

More information

Limiting the Duration of Medication Assisted Treatment for Opioid Addiction: Will New State Policies Help or Hurt?

Limiting the Duration of Medication Assisted Treatment for Opioid Addiction: Will New State Policies Help or Hurt? University of Massachusetts Medical School escholarship@umms Commonwealth Medicine Publications Commonwealth Medicine 6-25-2014 Limiting the Duration of Medication Assisted Treatment for Opioid Addiction:

More information

Management Options for Opioid Dependence:

Management Options for Opioid Dependence: Management Options for Opioid Dependence: Policy Implications and Recommendations Dan Ollendorf, PhD Sarah Jane Reed, MSc New England CEPAC Goal: To improve the application of evidence to guide practice

More information

Use of Reminder Messages to Improve Utilization of an Automated Telephone-Based Treatment for Methadone Patients

Use of Reminder Messages to Improve Utilization of an Automated Telephone-Based Treatment for Methadone Patients Use of Reminder Messages to Improve Utilization of an Automated Telephone-Based Treatment for Methadone Patients Destiny M.B. Printz, B.A. Daniel P. Lloyd, M.A. Frank D. Buono, Ph.D. Brent A. Moore, Ph.D.

More information

Opioid Treatment Program Reimbursement Re-bundling Proposal

Opioid Treatment Program Reimbursement Re-bundling Proposal Opioid Treatment Program Reimbursement Re-bundling Proposal Maryland Department of Health and Mental Hygiene April 22, 2016 The Department reviewed close to 50 letters and emails submitted by stakeholders

More information

STARTING SUBOXONE IN PRIMARY CARE

STARTING SUBOXONE IN PRIMARY CARE Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences STARTING SUBOXONE IN PRIMARY CARE MARK DUNCAN MD UNIVERSITY OF WASHINGTON OBJECTIVES 1. Review evidence of how to

More information

Allegany Rehabilitation Associates Personalized Recovery Oriented Services. PROS Service: Intensive Rehabilitation-Integrated Dual Disorder Treatment

Allegany Rehabilitation Associates Personalized Recovery Oriented Services. PROS Service: Intensive Rehabilitation-Integrated Dual Disorder Treatment Total Number of Sessions: Approximately 15 weeks Duration of each session: 45 minutes PROS Service: Intensive Rehabilitation-Integrated Dual Disorder Treatment Maximum number of participants: 8 Staff Qualifications:

More information

Trends and Challenges: The Kentucky Opioid Crisis. Jason Smith, MD PhD University of Louisville

Trends and Challenges: The Kentucky Opioid Crisis. Jason Smith, MD PhD University of Louisville Trends and Challenges: The Kentucky Opioid Crisis Jason Smith, MD PhD University of Louisville Brief Introduction I am by no means an expert I have no financial disclosures Jokes are meant to be lighthearted

More information

Models for Involvement in Physical Activity

Models for Involvement in Physical Activity Models for Involvement in Physical Activity Why do people embrace or do not embrace a physical active lifestyle? 1 Typical Undergrad Complaints What s the point? Aren t these all the same? What does this

More information

Project Connections Buprenorphine Program

Project Connections Buprenorphine Program Project Connections Buprenorphine Program Program & Client Summary 2010-2017 Behavioral Health Leadership Institute November 2017 November 2017 1 Table of Contents I. Overview of the Project Connections

More information

Substance Use Trends in the Military, Veteran and Family Population

Substance Use Trends in the Military, Veteran and Family Population Substance Use Trends in the Military, Veteran and Family Population Prepared by: Shana Malone Arizona Criminal Justice Commission Statistical Analysis Center National Illicit Drug Use 1 in 10 individuals

More information

Self-efficacy Evaluation Survey on Chinese Employees: Case of Electronics Limited Company X1 (Shenzhen) & Investments Company Limited X2 (Beijing)

Self-efficacy Evaluation Survey on Chinese Employees: Case of Electronics Limited Company X1 (Shenzhen) & Investments Company Limited X2 (Beijing) Self-efficacy Evaluation Survey on Chinese Employees: Case of Electronics Limited Company X (Shenzhen) & Investments Company Limited X2 (Beijing) Rodrigue Againglo*, Jun Shan Gao, Karani N. Nyachiro University

More information

OPIOIDS IN AMERICA. A complex crisis. A comprehensive response.

OPIOIDS IN AMERICA. A complex crisis. A comprehensive response. OPIOIDS IN AMERICA A complex crisis. A comprehensive response. Prescription opioids play a critical role in helping millions of people effectively manage chronic pain. But for some, opioid use has become

More information

HARM REDUCTION & TREATMENT. Devin Reaves MSW

HARM REDUCTION & TREATMENT. Devin Reaves MSW HARM REDUCTION & TREATMENT Devin Reaves MSW The mission of PAHRC is to promote the health, dignity, and human rights of individuals who use drugs and communities impacted by drug use. Recognizing that

More information

Buprenorphine as a Treatment Option for Opioid Use Disorder

Buprenorphine as a Treatment Option for Opioid Use Disorder Buprenorphine as a Treatment Option for Opioid Use Disorder Joji Suzuki, MD Assistant Professor of Psychiatry Harvard Medical School Director, Division of Addiction Psychiatry Brigham and Women s Hospital

More information

What is Treatment Planning? Clinical Evaluation: Treatment Planning Goals and Objectives

What is Treatment Planning? Clinical Evaluation: Treatment Planning Goals and Objectives Clinical Evaluation: Treatment Planning Goals and Objectives 1) Define Treatment Planning 2) Understanding of Correlation Between Assessment and Treatment Planning 3) Overview of Treatment Planning Process

More information

POLYSUBSTANCE USE IN THE TREATMENT OF OPIOID USE DISORDER WITH BUPRENORPHINE

POLYSUBSTANCE USE IN THE TREATMENT OF OPIOID USE DISORDER WITH BUPRENORPHINE Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences POLYSUBSTANCE USE IN THE TREATMENT OF OPIOID USE DISORDER WITH BUPRENORPHINE MARK DUNCAN, MD November 8, 2018 SPEAKER

More information

Kaiser Telecare Program for Intensive Community Support Intensive Case Management Exclusively for Members within a Managed Care System

Kaiser Telecare Program for Intensive Community Support Intensive Case Management Exclusively for Members within a Managed Care System Kaiser Telecare Program for Intensive Community Support Intensive Case Management Exclusively for Members within a Managed Care System 12-Month Customer Report, January to December, 2007 We exist to help

More information

THE IOWA CONSORTIUM FOR SUBSTANCE ABUSE RESEARCH AND EVALUATION. Special Report: Opioid Admissions in Iowa August 2016

THE IOWA CONSORTIUM FOR SUBSTANCE ABUSE RESEARCH AND EVALUATION. Special Report: Opioid Admissions in Iowa August 2016 Special Report: State of Iowa Opioid Treatment Admissions 21-215 THE IOWA CONSORTIUM FOR SUBSTANCE ABUSE RESEARCH AND EVALUATION Special Report: Opioid Admissions in Iowa 21-215 August 216 With Funds Provided

More information

Overview of Treatment Engagement Findings from DATOS

Overview of Treatment Engagement Findings from DATOS Drug Abuse Outcome Studies (Funded by NIDA) Overview of Engagement Findings from DATOS Charts Prepared & Released for Public Use by Dwayne Simpson (TCU), Robert Hubbard (NDRI-NC), Douglas Anglin (UCLA),

More information

From Opioid Overdose Prevention to Community Resilience CAPT Jeffrey Coady, Psy.D., ABPP SAMHSA Regional Administrator (Region 5)

From Opioid Overdose Prevention to Community Resilience CAPT Jeffrey Coady, Psy.D., ABPP SAMHSA Regional Administrator (Region 5) From Opioid Overdose Prevention to Community Resilience CAPT Jeffrey Coady, Psy.D., ABPP SAMHSA Regional Administrator (Region 5) Region 5 Fatherhood Initiative October 24, 2017 Today s Presentation Public

More information

15 INSTRUCTOR GUIDELINES

15 INSTRUCTOR GUIDELINES STAGE: Former Tobacco User You are a pharmacist at an anticoagulation clinic and are counseling one of your patients, Mrs. Friesen, who is a 60-year-old woman with a history of recurrent right leg deep

More information

Addiction Environmental Scan: Mapping Addictions in the Central East LHIN (CELHIN) - Defining the Gaps and Opportunities Project

Addiction Environmental Scan: Mapping Addictions in the Central East LHIN (CELHIN) - Defining the Gaps and Opportunities Project : Mapping Addictions in the Central East LHIN (CELHIN) - Defining the Gaps and Opportunities Project For further information please go to: http://www.health.gov.on.ca/english/public/program/mentalhealth/minister_advisgroup/m

More information

How serious is the opiate problem in Fairfield County?

How serious is the opiate problem in Fairfield County? How serious is the opiate problem in Fairfield County? The Use of Opiates in Fairfield County has increased from levels in the 1990's that were barely detectable to epidemic proportions in 2010. How serious

More information

Substance Use Disorders: A System Overview

Substance Use Disorders: A System Overview Substance Use Disorders: A System Overview For Senate Human Services and Early Childhood Karen Wheeler, M.A. Behavioral Health Programs Administrator Addictions and Mental Health Division Substance use

More information

In 2008, an estimated 282,000 persons

In 2008, an estimated 282,000 persons National Survey of Substance Abuse Treatment Services The N-SSATS Report January 28, 2010 Similarities and Differences in Opioid Treatment Programs that Provide Methadone Maintenance or Buprenorphine Maintenance

More information

ADVANCED BEHAVIORAL HEALTH, INC. Clinical Level of Care Guidelines

ADVANCED BEHAVIORAL HEALTH, INC. Clinical Level of Care Guidelines The Clinical Level of Care Guidelines contained on the following pages have been developed as a guide to assist care managers, physicians and providers in making medical necessity decisions about the least

More information

RECOMMENDATIONS FOR HEALTH CARE PROVIDERS

RECOMMENDATIONS FOR HEALTH CARE PROVIDERS Ending Addiction Changes Everything RECOMMENDATIONS FOR HEALTH CARE PROVIDERS CRITICAL ADDICTION PREVENTION, TREATMENT AND MANAGEMENT SERVICES TO INCLUDE IN ROUTINE HEALTH CARE PRACTICE JULY 2013 In the

More information

The Social Worker s Role in Medication Assisted Treatment

The Social Worker s Role in Medication Assisted Treatment The Social Worker s Role in Medication Assisted Treatment Rocky Ephraim Lucas, LICSW Behavioral Health Consultant, Kanawha City Health Center (Cabin Creek Health Systems) What is Medication-Assisted Treatment

More information

Brief History of Methadone Maintenance Treatment

Brief History of Methadone Maintenance Treatment METHADONE Brief History of Methadone Maintenance Treatment Methadone maintenance treatment was on the cusp of the social revolution in the sixties. Doctors and public health workers had concluded what

More information

Report to The Vermont Legislature. Substance Abuse Treatment Services Objectives and Performance Measures Progress: Second Annual Report

Report to The Vermont Legislature. Substance Abuse Treatment Services Objectives and Performance Measures Progress: Second Annual Report Report to The Vermont Legislature Substance Abuse Treatment Services Objectives and Performance Measures Progress: Second Annual Report In Accordance with Act 179 () Sec. E.306.2 (a)(2) Submitted to: Submitted

More information

Medication-Assisted Treatment. What Is It and Why Do We Use It?

Medication-Assisted Treatment. What Is It and Why Do We Use It? Medication-Assisted Treatment What Is It and Why Do We Use It? What is addiction, really? o The four C s of addiction: Craving. Loss of Control of amount or frequency of use. Compulsion to use. Use despite

More information

Outlook and Outcomes Fiscal Year 2011

Outlook and Outcomes Fiscal Year 2011 Baltimore Substance Abuse Systems, Inc. Outlook and Outcomes Fiscal Year 2011 Baltimore City Greg Warren, President Compiled July 2012 BSAS Outlook and Outcomes is the first edition of a planned annual

More information

Behavioral EQ MULTI-RATER PROFILE. Prepared for: By: Session: 22 Jul Madeline Bertrand. Sample Organization

Behavioral EQ MULTI-RATER PROFILE. Prepared for: By: Session: 22 Jul Madeline Bertrand. Sample Organization Behavioral EQ MULTI-RATER PROFILE Prepared for: Madeline Bertrand By: Sample Organization Session: Improving Interpersonal Effectiveness 22 Jul 2014 Behavioral EQ, Putting Emotional Intelligence to Work,

More information

Medication-Assisted Treatment (MAT) Overview

Medication-Assisted Treatment (MAT) Overview Medication-Assisted Treatment (MAT) Overview 2014 Opiate Conference: Don t Get Me Started Hyatt Regency, Columbus, Ohio June 30-July 1, 2014 Christina M. Delos Reyes, MD Medical Consultant, Center for

More information

Exploring the Relationship Between Substance Abuse and Dependence Disorders and Discharge Status: Results and Implications

Exploring the Relationship Between Substance Abuse and Dependence Disorders and Discharge Status: Results and Implications MWSUG 2017 - Paper DG02 Exploring the Relationship Between Substance Abuse and Dependence Disorders and Discharge Status: Results and Implications ABSTRACT Deanna Naomi Schreiber-Gregory, Henry M Jackson

More information

THE HEALTH BELIEF MODEL. Health Behavior CHAPTER 6

THE HEALTH BELIEF MODEL. Health Behavior CHAPTER 6 THE HEALTH BELIEF MODEL 1 DESCRIPTION This chapter will discuss The Health Belief Model, Protection Motivation Theory and how to use the model in the behavior case analysis 2 OBJECTIVES General The student

More information

ROSC & MAT II: Opioid Treatment Services

ROSC & MAT II: Opioid Treatment Services ROSC & MAT II: Opioid Treatment Services September 23, 2015 Stan DeKemper Executive Director Indiana Credentialing Association on Addiction and Drug Abuse 1 GOALS Review medication assisted recovery Identify

More information

Child Welfare and Substance Abuse. Erica Tarasovitch, MSW Central Florida Behavioral Health Network

Child Welfare and Substance Abuse. Erica Tarasovitch, MSW Central Florida Behavioral Health Network Child Welfare and Substance Abuse Erica Tarasovitch, MSW Central Florida Behavioral Health Network Parental Substance Use Marijuana was the most commonly used illicit drug in 2006, accounting for 72.8

More information

TWIN VALLEY BEHAVIORAL HEALTHCARE CLINICAL GUIDELINES FOR MANAGEMENT OF SMOKING CESSATION

TWIN VALLEY BEHAVIORAL HEALTHCARE CLINICAL GUIDELINES FOR MANAGEMENT OF SMOKING CESSATION Appendix G PHASE OF MANAGEMENT NOTIFICATION ASSESSMENT TWIN VALLEY BEHAVIORAL HEALTHCARE CLINICAL GUIDELINES FOR MANAGEMENT OF SMOKING CESSATION ACTIONS All patients will be advised on admission that :

More information

Self-efficacy, Positive Thinking, Gender Difference as Predictors of Academic Achievement in Al Jouf University Students-Saudi Arabia

Self-efficacy, Positive Thinking, Gender Difference as Predictors of Academic Achievement in Al Jouf University Students-Saudi Arabia International Journal of Psychology and Behavioral Sciences 207, 7(6): 43-5 DOI: 0.5923/j.ijpbs.2070706.0 Self-efficacy, Positive Thinking, Gender Difference as Predictors of Academic Achievement in Al

More information

Core Competencies - Smoking Cessation Fundamentals

Core Competencies - Smoking Cessation Fundamentals Core Competencies - Smoking Cessation Fundamentals This training standard was developed for the National Training Service (NTS) Alliance in consultation with subject matter experts. The purpose of this

More information

Counseling and Testing for HIV. Protocol Booklet

Counseling and Testing for HIV. Protocol Booklet Counseling and Testing for HIV Protocol Booklet JHPIEGO, an affiliate of Johns Hopkins University, builds global and local partnerships to enhance the quality of health care services for women and families

More information

FAMILY FUNCTIONAL THERAPY (FFT) - Youth. Program Description

FAMILY FUNCTIONAL THERAPY (FFT) - Youth. Program Description Clinical FAMILY FUNCTIONAL THERAPY (FFT) - Youth Program Description Family Functional Therapy (FFT) is a family-focused, community-based treatment for youth who are either at risk for, or who manifest,

More information

Your Child s Treatment Roadmap

Your Child s Treatment Roadmap Your Child s Treatment Roadmap The road to recovery isn t the same for everyone. There are many options to consider for your son, daughter, or loved one. Our guide outlines key steps to help you make the

More information

David O Malley, Ph.D., LISW Case Western Reserve University Cleveland, Ohio

David O Malley, Ph.D., LISW Case Western Reserve University Cleveland, Ohio An Examination of Factors Influencing College Students Self-Reported Likelihood of Calling for Assistance for A Fellow Student Who Has Engaged In High-Risk Alcohol Consumption David O Malley, Ph.D., LISW

More information

Opioid Treatment in North Carolina SEPTEMBER 13, 2016

Opioid Treatment in North Carolina SEPTEMBER 13, 2016 Opioid Treatment in North Carolina SEPTEMBER 13, 2016 Source Where Pain Relievers Were Obtained for Most Recent Nonmedical Use among Past Year Users Aged 12 or Older: 2007 Source Where Respondent Obtained

More information

American Addiction Centers Outcomes Study Long-Term Outcomes Among Residential Addiction Treatment Clients. Centerstone Research Institute

American Addiction Centers Outcomes Study Long-Term Outcomes Among Residential Addiction Treatment Clients. Centerstone Research Institute American Addiction Centers Outcomes Study Long-Term Outcomes Among Residential Addiction Treatment Clients Centerstone Research Institute 2018 1 AAC Outcomes Study: Long-Term Outcomes Executive Summary

More information

State of Iowa Outcomes Monitoring System

State of Iowa Outcomes Monitoring System State of Iowa Outcomes Monitoring System THE IOWA CONSORTIUM FOR SUBSTANCE ABUSE RESEARCH AND EVALUATION Year 17 Annual Outcome Evaluation Trend Report November 2015 With Funds Provided By: Iowa Department

More information

Organization: NAMI Minnesota Request ID: Program Title: Reducing Smoking Among People with Mental Illnesses

Organization: NAMI Minnesota Request ID: Program Title: Reducing Smoking Among People with Mental Illnesses Organization: NAMI Minnesota Request ID: 16872475 Program Title: Reducing Smoking Among People with Mental Illnesses 1. Overall Goal & Objectives The overall goal of this project is to reduce the rate

More information

DATA-DRIVEN JUSTICE: DISRUPTING THE CYCLE OF INCARCERATION. Biweekly Call December 14, 2016

DATA-DRIVEN JUSTICE: DISRUPTING THE CYCLE OF INCARCERATION. Biweekly Call December 14, 2016 DATA-DRIVEN JUSTICE: DISRUPTING THE CYCLE OF INCARCERATION Biweekly Call December 14, 2016 Data-Driven Justice Initiative Implementing Medication Assisted Treatment Programs for Justice Involved Populations

More information

Motivational Enhancement Therapy & Stages of Change

Motivational Enhancement Therapy & Stages of Change Motivational Enhancement Therapy & Stages of Change Learning Objectives Participants will be able to: 1) Identify the stages of change and how they can be implemented 2) Describe the principles of MET

More information

Substance Abuse Level of Care Criteria

Substance Abuse Level of Care Criteria Substance Abuse Level of Care Criteria Table of Contents SUBSTANCE ABUSE OUTPATIENT: Adolescent... 3 SUBSTANCE ABUSE PREVENTION: Adult... 7 OPIOID MAINTENANCE THERAPY: Adult... 8 SUBSTANCE ABUSE INTERVENTION:

More information

The Role of Primary Care Teams and the Medical Neighborhood in Addressing the Opioid Crisis in Maine. March 10, 2016

The Role of Primary Care Teams and the Medical Neighborhood in Addressing the Opioid Crisis in Maine. March 10, 2016 The Role of Primary Care Teams and the Medical Neighborhood in Addressing the Opioid Crisis in Maine March 10, 2016 Objectives Review current state of opioid crisis in Maine Briefly review physiology of

More information

Johann Hari. Truths 2/29/2016. From the street to the NICU. Treatment works

Johann Hari. Truths 2/29/2016. From the street to the NICU. Treatment works From the street to the NICU Richard Christensen, PA, CAS Johann Hari Treatment works Truths Disconnect with pregnant women seeking treatment Disconnect between community and science Medication is not a

More information

DESCRIPTION OF FOLLOW-UP SAMPLE AT INTAKE SECTION TWO

DESCRIPTION OF FOLLOW-UP SAMPLE AT INTAKE SECTION TWO SECTION TWO DESCRIPTION OF FOLLOW-UP SAMPLE AT INTAKE 7 2.1 DEMOGRAPHIC CHARACTERISTICS Table 2.1 presents demographic descriptive data at intake for those who were included in the follow-up study. Data

More information

EXPERT PANEL AND FIELD PARTICIPANTS BELIEVE

EXPERT PANEL AND FIELD PARTICIPANTS BELIEVE EXPERT PANEL AND FIELD PARTICIPANTS BELIEVE 1. The overall total number of clients/cases/patients in the system has remained stable over the years; however, the proportional number of clients abusing opiates

More information

TREATING OPIOID ADDICTION IN HOMELESS POPULATIONS

TREATING OPIOID ADDICTION IN HOMELESS POPULATIONS TREATING OPIOID ADDICTION IN HOMELESS POPULATIONS Challenges and Opportunities Providing Medication Assisted Treatment (Buprenorphine) August 18, 2016 SPEAKERS TODAY Nilesh Kalyanaraman, MD, Chief Health

More information

Georgia Aging and Disability Resource Connection (ADRC) Evaluation Report

Georgia Aging and Disability Resource Connection (ADRC) Evaluation Report Georgia Aging and Disability Resource (ADRC) Evaluation Report Evaluation Report from Boston University March Prepared by: Bronwyn Keefe, MSW, MPH, PHD Associate Director, CADER Kathy Kuhn, MSW Director

More information

State of Iowa Outcomes Monitoring System

State of Iowa Outcomes Monitoring System State of Iowa Outcomes Monitoring System THE IOWA CONSORTIUM FOR SUBSTANCE ABUSE RESEARCH AND EVALUATION Year 16 Annual Outcome Evaluation Trend Report November 2014 With Funds Provided By: Iowa Department

More information

CHARACTERISTICS OF ADMISSIONS TO RESIDENTIAL DRUG TREATMENT AGENCIES IN NEW SOUTH WALES, : ALCOHOL PROBLEMS

CHARACTERISTICS OF ADMISSIONS TO RESIDENTIAL DRUG TREATMENT AGENCIES IN NEW SOUTH WALES, : ALCOHOL PROBLEMS CHARACTERISTICS OF ADMISSIONS TO RESIDENTIAL DRUG TREATMENT AGENCIES IN NEW SOUTH WALES, 1988-1992: ALCOHOL PROBLEMS Shane Darke 1, Margaret Kelahar 1, Wayne Hall 1 & Bruce Flaherty 2 1 National Drug and

More information

7/7/2016 Journal of the American Medical Association,

7/7/2016 Journal of the American Medical Association, 1 2 Journal of the American Medical Association, 2008 3 The Clinical Trial 152 Adolescents and Young Adults (Age 15 to 21) randomly assigned to either; 1. 2 weeks of Buprenorphine detox 2. 12 weeks of

More information

MEDICATION ASSISTED TREATMENT PRESCRIPTION DRUG AND OPIOID ADDICTION THE IOWA CONSORTIUM FOR SUBSTANCE ABUSE RESEARCH AND EVALUATION

MEDICATION ASSISTED TREATMENT PRESCRIPTION DRUG AND OPIOID ADDICTION THE IOWA CONSORTIUM FOR SUBSTANCE ABUSE RESEARCH AND EVALUATION MEDICATION ASSISTED TREATMENT PRESCRIPTION DRUG AND OPIOID ADDICTION THE IOWA CONSORTIUM FOR SUBSTANCE ABUSE RESEARCH AND EVALUATION Year One Annual Evaluation Report September 2016 With Funds Provided

More information

Family & Children s Services MENTAL HEALTH SERVICES FOR ADULTS

Family & Children s Services MENTAL HEALTH SERVICES FOR ADULTS Family & Children s Services MENTAL HEALTH SERVICES FOR ADULTS You don t have to suffer from mental illness. We re here to help you with problems that seem overwhelming and too difficult to handle alone.

More information

*IN10 BIOPSYCHOSOCIAL ASSESSMENT*

*IN10 BIOPSYCHOSOCIAL ASSESSMENT* BIOPSYCHOSOCIAL ASSESSMENT 224-008B page 1 of 5 / 06-14 Please complete this questionnaire and give it to your counselor on your first visit. This information will help your clinician gain an understanding

More information

TITLE: Naltrexone for the Treatment of Alcohol Dependence in Individuals with Co- Dependencies: A Review of the Clinical Effectiveness

TITLE: Naltrexone for the Treatment of Alcohol Dependence in Individuals with Co- Dependencies: A Review of the Clinical Effectiveness TITLE: Naltrexone for the Treatment of Alcohol Dependence in Individuals with Co- Dependencies: A Review of the Clinical Effectiveness DATE: 08 October 2009 CONTEXT AND POLICY ISSUES: Poly-drug abuse is

More information

Evolutions Recovery House

Evolutions Recovery House Evolutions Recovery House General Information Contact Information nprofit Evolutions Recovery House Address 1261 1st Avenue rth Nashville, TN 37210 Phone (615) 593-4387 Fax 615 242-8690 Web Site Web Site

More information

Behavioral Health Hospital and Emergency Department Health Services Utilization

Behavioral Health Hospital and Emergency Department Health Services Utilization Behavioral Health Hospital and Emergency Department Health Services Utilization Rhode Island Fee-For-Service Medicaid Recipients Calendar Year 2000 Prepared for: Prepared by: Medicaid Research and Evaluation

More information

Arwen Podesta, MD. ABIHM, ABAM, Forensic Psychiatry

Arwen Podesta, MD. ABIHM, ABAM, Forensic Psychiatry The State of Medicine in Addiction Recovery Arwen Podesta, MD ABIHM, ABAM, Forensic Psychiatry www.podestawellness.com 504-252-0026 http://www.addictionpolicy.org/ Overview Addiction is a serious, chronic

More information

What Is Heroin? Examples of Opioids. What Science Says about Opioid Use Disorder and Its Treatment 6/27/2016

What Is Heroin? Examples of Opioids. What Science Says about Opioid Use Disorder and Its Treatment 6/27/2016 What Science Says about Opioid Use Disorder and Its Treatment Perilou Goddard, Ph.D. Department of Psychological Science Northern Kentucky University Examples of Opioids Agonists (activate opioid receptors)

More information

TRENDS IN SUBSTANCE USE AND ASSOCIATED HEALTH PROBLEMS

TRENDS IN SUBSTANCE USE AND ASSOCIATED HEALTH PROBLEMS Fact Sheet N 127 August 1996 TRENDS IN SUBSTANCE USE AND ASSOCIATED HEALTH PROBLEMS Psychoactive substance use is an increasing public health concern. Problems associated with this use cover a broad spectrum

More information

Substance Abuse Group Therapy

Substance Abuse Group Therapy Substance Abuse Group Therapy Multiple Choice Identify the choice that best completes the statement or answers the question. 1. Chapter 1 This natural propensity in humans makes group therapy a powerful

More information

Andreas Bund University of Darmstadt. Self-Confidence and Sports Performance

Andreas Bund University of Darmstadt. Self-Confidence and Sports Performance University of Darmstadt Self-Confidence and Sports Performance Self-Confidence and Sports Performance 2. Theoretical and Motor Performance (Moritz et al., 2000) and Motor Learning (Bund, 2001) Statements

More information

BASIC VOLUME. Elements of Drug Dependence Treatment

BASIC VOLUME. Elements of Drug Dependence Treatment BASIC VOLUME Elements of Drug Dependence Treatment Module 2 Motivating clients for treatment and addressing resistance Basic counselling skills for drug dependence treatment Special considerations when

More information

Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center

Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center Data from the National Vital Statistics System Mortality The age-adjusted rate of drug overdose deaths in the United States

More information